We are live on ! Find out more
CFB

Cullen/Frost Bankers Portfolio holdings

AUM $10.1B
1-Year Est. Return 29.18%
This Fund
S&P 500
This Quarter Est. Return
+10.77%
1 Year Est. Return
+29.18%
3 Year Est. Return
+91.06%
5 Year Est. Return
+115.39%
10 Year Est. Return
+478.9%
AUM
$5.26B
AUM Growth
+$308M
Cap. Flow
-$146M
Cap. Flow %
-2.78%
Top 10 Hldgs %
27.62%
Holding
1,387
New
167
Increased
209
Reduced
399
Closed
146

Top Sells

Rank Stock Value
1
CVX icon
Chevron
CVX
+$28.6M
2
KSU
Kansas City Southern
KSU
+$18.8M
3
MSFT icon
Microsoft
MSFT
+$13.1M
4
AAPL icon
Apple
AAPL
+$12M
5
AMZN icon
Amazon
AMZN
+$7.76M

Sector Composition

Rank Sector Weight
1 Technology 23.51%
2 Financials 12.43%
3 Healthcare 10.99%
4 Consumer Discretionary 10.9%
5 Communication Services 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEP icon
51
PepsiCo
PEP
$187B
$27.9M 0.53%
160,441
-4,153
-3% -$678K
MRVL icon
52
Marvell Technology
MRVL
$200B
$27.5M 0.52%
314,800
-801
-0.3% -$59.8K
MCO icon
53
Moody's
MCO
$82B
$27.2M 0.52%
69,740
-3,197
-4% -$1.23M
GLW icon
54
Corning
GLW
$143B
$25.5M 0.49%
685,729
-20,991
-3% -$786K
MRK icon
55
Merck
MRK
$326B
$25.3M 0.48%
329,806
-27,303
-8% -$2.17M
NDAQ icon
56
Nasdaq
NDAQ
$53B
$24.9M 0.47%
354,996
-9,186
-3% -$626K
MDT icon
57
Medtronic
MDT
$114B
$24.7M 0.47%
238,100
-5,554
-2% -$643K
HON icon
58
Honeywell
HON
$73.2B
$24M 0.46%
122,090
-1,087
-0.9% -$219K
CVS icon
59
CVS Health
CVS
$120B
$23.9M 0.45%
231,192
-3,190
-1% -$295K
MCD icon
60
McDonald's
MCD
$192B
$23.8M 0.45%
88,617
-2,253
-2% -$569K
BKNG icon
61
Booking.com
BKNG
$157B
$22.7M 0.43%
236,250
-4,750
-2% -$450K
VWO icon
62
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$22.1M 0.42%
447,021
+164,743
+58% +$8.31M
CMG icon
63
Chipotle Mexican Grill
CMG
$41.5B
$21.9M 0.42%
627,550
-29,250
-4% -$1.03M
NKE icon
64
Nike
NKE
$60.2B
$21.9M 0.42%
131,400
-4,645
-3% -$766K
VOO icon
65
Vanguard S&P 500 ETF
VOO
$1.03T
$21.7M 0.41%
49,745
+50
+0.1% +$21.1K
VZ icon
66
Verizon
VZ
$194B
$21.3M 0.4%
409,008
-21,719
-5% -$1.13M
LRCX icon
67
Lam Research
LRCX
$409B
$20.9M 0.4%
290,400
-8,650
-3% -$542K
PM icon
68
Philip Morris
PM
$291B
$20.5M 0.39%
215,609
-10,382
-5% -$970K
STT icon
69
State Street
STT
$52.1B
$20.5M 0.39%
220,027
-600
-0.3% -$56.6K
EW icon
70
Edwards Lifesciences
EW
$53.1B
$19.8M 0.38%
152,572
-5,088
-3% -$593K
WDAY icon
71
Workday
WDAY
$42.8B
$19.3M 0.37%
70,690
+1,341
+2% +$372K
ADP icon
72
Automatic Data Processing
ADP
$106B
$19.1M 0.36%
77,445
-1,677
-2% -$380K
AMT icon
73
American Tower
AMT
$79.2B
$19M 0.36%
64,955
-2,753
-4% -$752K
T icon
74
AT&T
T
$167B
$18.6M 0.35%
1,001,513
+49,201
+5% +$920K
AXP icon
75
American Express
AXP
$229B
$18.6M 0.35%
113,578
-8,141
-7% -$1.39M

Similar funds

Cullen/Frost Bankers's Q4 2021 Portfolio in Review

As of Q4 2021, Cullen/Frost Bankers held 1,387 positions worth $5.26B, up 6.2% from $4.95B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Cullen/Frost Bankers's Q4 2021 filing shows 167 new, 209 increased, 399 reduced and 146 closed positions. Its largest new stake was Sprott Physical Gold and Silver Trust: 64,850 shares worth $1.15M. The largest sale was Chevron, an estimated $28.6M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • Cullen/Frost Bankers's largest Q4 2021 buy was Sprott Physical Gold and Silver Trust: 64,850 shares worth $1.15M.
  • Cullen/Frost Bankers added most to Vanguard FTSE Emerging Markets ETF in Q4 2021, an estimated $8.31M increase.
  • Cullen/Frost Bankers's biggest Q4 2021 reduction was Chevron, cutting an estimated $28.6M.
  • Cullen/Frost Bankers fully exited Kansas City Southern in Q4 2021, selling an estimated $18.8M.
  • Cullen/Frost Bankers's ten largest holdings make up 28% of its $5.26B portfolio in Q4 2021.
  • Cullen/Frost Bankers opened 167 new positions and closed 146 in Q4 2021.
  • Cullen/Frost Bankers's portfolio value rose 6.2% quarter-over-quarter to $5.26B.

Based on Cullen/Frost Bankers's 13F filing for Q4 2021, filed 7 Feb 2022.